Studies were carried out to test the hypothesis that inflammatory liver disease increases the expression of specific cytochrome P-450 isoenzymes involved in aflatoxin B 1 (AFB) activation. The immunohistochemical expression and localization of various human cytochrome P-450 isoforms, including CYP2A6, CYP1A2, CYP3A4, and CYP2B1, were examined in normal human liver and liver with hepatitis and cirrhosis. The constitutive expression of CYP3A4 in normal liver showed a characteristic pattern of distribution in centrilobular hepatocytes, whereas CYP1A2, CYP2A6, and CYP2B1 1 were expressed uniformly throughout the liver acinus. In sections of liver infected with hepatitis B virus (HBV) or hepatitis C virus (HCV), the expression of CYP2A6 was markedly increased in hepatocytes immediately adjacent to areas of fibrosis and inflammation. CYP3A4 and CYP2B 1 were induced to a lesser degree, and expression of CYP1A2 was unaffected. In HBV-infected liver, double immunostaining revealed that overexpression of CYP2A6 occurred in hepatocytes expressing the HBV core antigen. In HCV-infected liver, CYP2A6, CYP3A4, and CYP2B 1 were overexpressed in hepatocytes with hemosiderin pigmentation. These results suggest that alterations in phenotypic expression of specific P-450 isoenzymes in hepatocytes associated with hepatic inflammation and cirrhosis might increase susceptibility to AFB genotoxicity.
INTRODUCTION
Hepatocellular carcinoma (HCC) is a major cause of cancer mortality in areas such as southern China and sub-Saharan Africa where both infection with hepatitis B virus (HBV) and exposure to aflatoxin Bl (AFB) occurs. Epidemiological studies indicate a possible synergism between dietary consumption of AFB and other risk factors including chronic active viral hepatitis (CAH) (34, 44, 47) or consumption of alcoholic beverages (8) in the etiopathogenesis of HCC. For example, in prospective epidemiological studies in southern China using urinary biomarkers of aflatoxin exposure, a 12-fold higher relative risk of liver cancer was observed in HBsAg carriers with detectable urinary aflatoxin metabolites compared to carriers without urinary metabolites (36, 40) . While these molecular epidemiological studies support an apparent in-teraction between viral and chemical factors in hepatocarcinogenesis, the underlying molecular mechanisms are unclear. Several mechanistic explanations have, however, been proposed including the possibility that CAH might alter the metabolism of AFB (20, 21, 28) .
Experimental evidence indicates that the mechanistic basis for susceptibility to AFB hepatotoxicity and hepatocarcinogenicity is related to the capacity of the hepatic cytochrome P-450 (P-450)-dependent monooxygenase system to bioactivate AFB to the genotoxic metabolite AFB-8,9-epoxide as well as glutathione S-transferasemediated detoxification of this metabolite (30, 31, 37) .
Recent studies examining AFB metabolism by human microsomes and cell lines have demonstrated that multiple forms of human P450s, including cytochromes from the lA, 2A, 3A, and 2B gene families are capable of bioactivating AFB (2, 10-12, 15, 25, 38) . Considerable individual variability exists in the levels of expression of these isozymes (14) , in the degree of activation of AFB by human liver microsomes in vitro ( 15) and in the formation of the AFB-N 7-guanine adduct (3) . A knowledge of the genetic and environmental factors that influence this variability in P-450 expression and activity is im-portant in determining the relative individual susceptibility to liver cancer in human populations exposed to AFBthrough the diet.
We have previously demonstrated that overexpression of Cyp2a and 3a isoenzymes occurs in hepatocytes from 2 animal models of hepatitis, namely an HBV transgenic mouse lineage in which the HBV large envelope protein is overexpressed (23) and in Syrian hamsters infested with the human liver fluke Opisthorchis viverinni (24) . Furthermore, analysis of P-450 gene expression in 2 _ cases of cirrhotic human liver by in situ hybridization demonstrated high expression of CYP2A, CYP2B, and n CYP3A genes in hepatocytes adjacent to areas of fibrosis (32) . These findings suggest that liver injury and hepatitis might be important mediators of carcinogen metabolism z and susceptibility to liver cancer by modulating the exj pression of specific P-450 isoforms. In the present study, . Samples of normal liver (n = 3) originated either from liver transplant specimens or from normal liver surrounding primary or metastatic liver neoplasms. Diseased liver (n = 8) consisted of cases of cirrhosis of various etiologies including HCV or HBV chronic active hepatitis and Budd-Chiari syndrome. All tissues were fixed in 10% buffered formalin solution within 30 min of removal and embedded in paraffin wax according to standard procedures. Five-/-Lm sections were collected onto gelatin-coated slides and stored at room temperature until use. Hemosiderin was demonstrated in liver sections with Perl's iron stain as previously described (35) .
The objective of this study was to examine the influence of hepatitis and cirrhosis/fibrosis on cytochrome P-450 expression. To achieve this objective, cases of cirrhosis and fibrosis of differing etiologies (i.e., hepatitis viruses, alcohol, and Budd-Chiari syndrome) were included in the study. Budd-Chiari syndrome is characterized by thrombosis of hepatic veins, congestion, and in chronic cases, such as the one in this study, necrosis of centilobular hepatocytes, fibrin deposition and fibrosis of central zones, and nodule formation. The fibrosis observed in Budd-Chiari syndrome, however, is not severe enough to be termed cirrhosis. Comparison of fibrosis due to different etiologies allows for the assessment of the modifying influence of varying degrees of fibrosis on cytochrome P-450 expression.
Immunohistochemistry. The polyclonal antibodies to (15) . Five-/-Lm sections of liver were deparaffinized in xylene and rehydrated, and 5% low-fat milk was used to block nonspecific protein interactions. Endogenous peroxidase activity was quenched by incubation in 0.03% hydrogen peroxide for 10 min at room temperature. Slides were incubated overnight at 4°C with primary antibodies at appropriate dilutions (ranging from 100 to 1,000 times). All (6, 15) or by immunoblot analysis. A negative control was used in each case in which preimmune antiserum was used instead of primary antibody.
RESULTS
Clinical Data on Tissues Studied Table I summarizes clinical information about the sources of human liver tissue studied. Of the 8 cases of diseased liver, 4 were positive for either HBcAg or HBsAg, 2 were HCV-positive, and all had cirrhosis with some degree of inflammation. Control livers were derived from normal liver surrounding primary or metastatic liver tumors or from liver from transplant donors. Cases of alcoholic cirrhosis and Budd-Chiari syndrome were included to provide cases of hepatic fibrosis of differing etiology. Fig. 2a showing increased expression of CYP2A6 in hepatocytes at periphery of cirrhotic nodules bordering on area of fibrosis. All cytochromes P-450 were detected using polyclonal rabbit antihuman or anti-rat P-450 antibody and the avidin-biotin technique. X 100. 
Immunohistochemical Localization of Hepatic P-450s
The immunohistochemical expression of P-450s capable of activating AFB in human liver were examined in both normal liver and liver with hepatitis and cirrhosis due to various etiologies including HBV, HCV, and alcoholic cirrhosis and Budd-Chiari syndrome (Figs. 1-5 ). The distribution of these proteins in normal liver has been reported previously (6, 16, 19, 29) and our results were in concordance with those studies. In normal liver, the expression of CYP3A4 (Fig. la ) was regionally localized to hepatocytes surrounding terminal hepatic venules (Zone 3) with diminished expression toward the portal tracts. The expression of CYP2A6 (Fig. lb) and 2B 1 (not shown) was less abundant and occurred homogenously throughout the hepatic acinus. Figures 2-5 show the results of immunohistochemical staining in human liver with hepatitis. Overexpression of CYP2A6, CYP3A4, and CYP2B 1 was observed to varying degrees in all cases of hepatitis and cirrhosis irrespective of etiology. Of all P-450 isoenzymes examined, the increased expression of CYP2A6 was the most marked, followed to a lesser extent by CYP3A4. Increased granular cytoplasmic immunoreactive staining was observed predominantly in hepatocytes at the periphery of cirrhotic nodules immediately adjacent to areas of periportal inflammation and fibrosis (Fig. 2b ). Increased CYP2A6 expression occurred concurrently with HBcAg expression in HBV-infected liver (Fig. 3 ). In a case of Budd-Chiari syndrome CYP2A6, immunostaining was intense in individual hepatocytes randomly dispersed throughout the hepatic parenchyma ( Fig. 4 ). Sections of a case HCV-infected liver showed marked induction of 4 P-450 isoforms including CYP2A6, CYP3A4, CYP2B l, and CYP1A1 (Fig. 5a -c) in hepatocytes that had accumulated hemosiderin pigment in periportal regions of cirrhotic nodules, which was confirmed by Perl's iron stain (Fig. 5d ).
DISCUSSION
The results of this study shows that specific cytochrome P-450 isoenzymes that are involved in AFB activation in human liver are overexpressed in association with hepatitis and cirrhosis. This induction is regionally distributed, occurring in isolated hepatocytes located at the junction of cirrhotic nodular parenchyma and areas of fibrosis and inflammation. The significance of this P-450 induction is remarkable in view of (a) the intensity of induction, (b) the shift in distribution with respect to constitutive expression of immunoreactive protein in normal liver, and (c) the close association of hepatocytes displaying induced P-450s with areas of inflammation. The distribution of P-450 immunoreactivity in normal liver in which CYP3A4 is preferentially expressed in the centrilobular region (Zone 3) and CYP2A6, CYP2B 1, and CYPIA2 are uniformly throughout the liver acinus is in agreement with previous findings (3) . The shift in regional distribution of P-450 overexpression to hepatocytes in areas of inflammation suggests a possible association with the inflammatory process. We have shown a similar induction of Cyp2a and Cyp3a isoenzymes with hepatitis and liver injury in a transgenic lineage that overexpresses the HBsAg (23) . Furthermore, AFB-DNA adducts occurred in hepatocytes with induced Cyp2a-5 in HBV transgenic mice treated with AFBI, suggesting an increased susceptibility to AFB genotoxicity with P-450 induction. Induction of Cyp2a expression and AFB adduct formation was also observed at the periphery of cirrhotic nodules in livers of hamster infested with the human liver fluke (Opisthorchis viverrini) (24) . In a limited study of P-450 expression in 2 cases of cirrhotic liver by in situ hybridization, CYP2A, CYP2B, and CYP3A were highly expressed in isolated hepatocytes adjacent to areas of fibrosis (32) . Furthermore, a case control study has demonstrated increased CYP3A4 activity in healthy HBsAg carriers (19) . Regulatory sequences that determine region-specific expression of genes encoding a number of hepatic metabolizing enzymes have been identified (33) . As yet unidentified sequences involved in the regulation of P-450 gene expression could be potential targets, by similar mechanisms, of factors involved in the inflammatory process described in this study.
There is considerable evidence demonstrating that episodes of infectious disease result in suppression of the mixed function oxidase system and associated drug metabolism (26, 39) . Most of the studies are based on total P-450 activity and relatively few studies have examined the expression and activity of individual P-450 isoenzymes, particularly at the cellular level. In previous studies, we have shown that, while total P-450 expression may be reduced during hepatitis, individual P-450 isoenzymes may be increased, particularly when expressed as a function of P-450 concentrations rather than total microsomal protein concentration (23, 24) . A possible explanation is that increases in P-450 expression that are localized to certain zones of the liver or to individual hepatocytes might be diluted out in total liver microsome preparations. The significance of cellular level of increased expression of P-450s involved in carcinogen bioactivation needs further examination.
The mechanism behind overexpression of P-450 isoenzymes during hepatitis and cirrhosis remains to be illucidated. In view of the regional distribution of P-450 isoforms shown in this and other studies, it is possible that an inflammatory factor (i.e., cytokine or growth factor) might be regulating local expression of P-450s in liver disease. Specific cytokines and growth factors including interleukin 1 (IL-1), interleukin 6, tumor necrosis factor a, and transforming growth factor ~3 (TGF-¡3) are consistently elevated in acute and chronic hepatitis (13) . While the majority of studies in vivo and in vitro have shown that cytokines downregulate total or individual he- patic P-450 isoenzyme expression, it is currently not known which cytokines are directly involved or whether or not certain isoforms of P-450 are selectively affected (4, 17, 42) . For example, gamma interferon decreases expression of CYP4A (39) but IL-1 increases CYP4A 1 expression (5) , suggesting that P-450 may be both positively and negatively regulated by cytokines. Finally, we have recently shown that exposure of primary mouse hepatocytes to TGF-J3 in culture results in a marked increase in Cyp2a-5 expression, suggesting a potential role for this growth factor in the regulation of P-450 expression (18) .
The significance of increased cytochrome P-450 expression in hemosiderin-laden hepatocytes is uncertain; however, there are 2 possible explanations. The cytochromes P-450 are a family of iron-containing hemoproteins. In vivo studies have shown that oral administration of iron enhances hepatic toxicity and carcinogenicity in rodents exposed to various xenobiotics and has been associated with altered P-450 expression and activity (27, 41) . Heme has also been shown to be a positive regulator of cytochrome P-450 gene transcription (7) . The precise role of iron in the regulation of CYP2A6 expression has not yet been examined directly in this study.
The concurrent induction of CYP2A6 and HBcAg expression in hepatocytes in this study and Cyp2a-5 induction in the study on HBV transgenic mice suggest an involvment of HBV or the pathologic consequences of HBV expression in enzyme induction. There is, however, no information as to whether or not HBV genes and their products influence specific hepatic P-450 gene expression. Specific elements of the HBV genome such as the HBX gene product that have transcriptional trans-activating capabilities (43) could conceivably be involved in P-450 induction. Accumulation of the HBV large envelope polypeptide in the endoplasmic reticulum of hepatocytes of transgenic mice is directly cytotoxic to hepatocytes (9) . Because cellular injury has been associated with the induction of expression of some cellular genes (1), these ultrastructural changes of the endoplasmic reticulum might affect the expression and activity of P-450 isoenzymes involved in the bioactivation of carcinogens.
The significance of altered metabolic function in hepatocytes of diseased liver with respect to liver cancer risk is potentially important. The hypothesis that HBVmediated liver injury might influence aflatoxin metabolism in humans is supported by a recent study of serum markers of AFB in Gambian children. A significantly higher level of serum aflatoxin-albumin adduct levels were detected in patients who were also seropositive for HBsAg (46) or those who had indirect evidence of liver damage (i.e., elevated serum levels of liver enzymes of alanine aminotransferase and aspartate aminotransferase) (45) . The accumulated data cited previously suggest that inflammation may be an important component when present. The elucidation of a mechanistic link between chronic infection/inflammation and malignant transformation could be important not only with respect to hepatitis and liver cancer but also in the context of the many other human tumors that develop in association with inflammation.
